Claritin Tablet, Chewable
Product Images NDC 11523-4331

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Claritin (NDC 11523-4331). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bayer Healthcare Llc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton (Cropped 1)

This is a description of Children's Loratadine, a non-drowsy antihistamine medication in chewable tablet form. It provides up to 24 hours of relief from symptoms related to indoor and outdoor allergies, including but not limited to sneezing, runny nose, itchy and watery eyes, and itchy throat or nose. The active ingredient of the medication is Loratadine 5 mg/antihistamine.*

FDA Label Image

Carton 2 (Cropped 2)

This is a drug facts label for particular tablets containing 5 mg of Loratadine as the active ingredient, which is an antihistamine intended to temporarily relieve symptoms of hay fever and upper respiratory allergies. The label provides guidance on directions for use for adults and children, and warns of potential side-effects, including drowsiness, the risk of overdose and allergic reactions. It cautions against use if the patient has known allergies or has liver or kidney issues. It includes a list of inactive ingredients and instructions on safe storage conditions.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.